Histochemistry and Cell Biology

, Volume 124, Issue 2, pp 139–149

Expression of versican in relation to chondrogenesis-related extracellular matrix components in canine mammary tumors

  • I. Erdélyi
  • A. J. A. M. van Asten
  • J. E. van Dijk
  • H. Nederbragt
Original paper

Abstract

Versican plays a role in tumor cell proliferation and adhesion and may also regulate cell phenotype. Furthermore, it is one of the pivotal proteoglycans in mesenchymal condensation during prechondrogenesis. We have previously demonstrated accumulation of versican protein in myoepithelial-like spindle cell proliferations and myxoid tissues of complex and mixed mammary tumors of dogs. The objective of this study was to investigate whether the high expression of versican relates to prechondrogenesis in these tissues. Therefore, we aimed to identify cartilage markers, such as collagen type II and aggrecan both at mRNA and protein level in relation to versican. The neopitope of chondoitin-6-sulphate (3B3) known to be generated in developing cartilage has been investigated by immunohistochemisty and a panel of antibodies were used to characterize the phenotype of cells that are involved in cartilage formation. In addition, co-localization of versican with hyaluronan and link protein was studied. RT-PCR revealed upregulation of genes of versican, collagen type II and aggrecan in neoplastic tissues, especially in complex and mixed tumors. Immunohistochemistry showed the expression of cartilage biomarkers not only in the cartilagenous tissues of mixed tumors, but also in myoepitheliomas and in the myoepithelial-like cell proliferations and myxoid areas of complex and mixed tumors. The results show the cartilagenous differentiation of complex tumors and myoepitheliomas and indicate that the myxoid tissues and myoepithelial-like cell proliferations are the precursor tissues of the ectopic cartilage in mixed tumors. Furthermore, we suggest that cartilage formation in canine mammary tumors is a result of (myo)epithelial to mesenchymal transition.

Keywords

Versican Cartilage biomarkers Hyaluronan Extracellular matrix Canine mammary tumors 

References

  1. Aigner T, Muller S, Neureiter D, Illstrup DM, Kirchner T, Bjornsson J (2002) Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomas. Cancer 94:2273–2281CrossRefPubMedGoogle Scholar
  2. Arai K, Uehara K, Nagai Y (1989) Expression of type-II and type-XI collagens in canine mammary mixed tumors and demonstration of collagen production by tumor cells in collagen gel culture. Jpn J Cancer Res 80:840–847PubMedGoogle Scholar
  3. Arai K, Uehara K, Nagai Y (1995) Simultaneous expression of type-IX collagen and an inhibin-related antigen in proliferative myoepithelial cells with pleomorphic adenoma of canine mammary glands. Jpn J Cancer Res 86:577–584PubMedGoogle Scholar
  4. Asher R, Perides G, Vanderhaeghen JJ, Bignami A (1991) Extracellular matrix of central nervous system white matter—demonstration of an hyaluronate-protein complex. J Neurosci Res 28:410–421CrossRefPubMedGoogle Scholar
  5. Bignami A, Perides G, Rahemtulla F (1993) Versican, a hyaluronate-binding proteoglycan of embryonal precartilagenous mesenchyma, is mainly expressed postnatally in rat brain. J Neurosci Res 34:97–106CrossRefPubMedGoogle Scholar
  6. Bishop PN, Reardon AJ, McLeod D, Ayad S (1994) Identification of alternatively spliced variants of type II procollagen in vitreous. Biochem Biophys Res Commun 203:289–295CrossRefPubMedGoogle Scholar
  7. Calabro A, Hascall VC, Caterson B (1992) Monoclonal antibodies directed against epitopes within the core protein structure of the large aggregated proteoglycan (aggrecan) from the Swarm rat chondrosarcoma. Arch Biochem Biophys 298:349–360CrossRefPubMedGoogle Scholar
  8. Caterson B, Mahmoodian F, Sorrell JM, Hardingham TE, Bayliss MT, Carney SL, Ratcliffe A, Muir H (1990) Modulation of native chondroitin sulfate structure in tissue development and in disease. J Cell Sci 97:411–417PubMedGoogle Scholar
  9. Destexhe E, Lespagnard L, Degeyter M, Heymann R, Coignoul F (1993) Immunohistochemical identification of myoepithelial, epithelial, and connective tissue cells in canine mammary tumors. Vet Pathol 30:146–154PubMedGoogle Scholar
  10. Dours-Zimmermann MT, Zimmermann DR (1994) A novel glycosaminoglycan attachment domain identified in two alternative splice variants of human versican. J Biol Chem 269:32992–32998PubMedGoogle Scholar
  11. du Cros DL, LeBaron RG, Couchman JR (1995) Association of versican with dermal matrices and its potential role in hair follicle development and cycling. J Invest Dermatol 105:426–431CrossRefPubMedGoogle Scholar
  12. Erdelyi I, Nieskens DHM, Dijk JE, Vass L, Nederbragt H (2003) Immunohistochemical evaluation of versican, in relation to chondroitin sulphate, in canine mammary tumors. Histol Histopath 18:1067–1080Google Scholar
  13. Gartner F, Geraldes M, Cassali G, Rema A, Schmit F (1999) DNA measurement and immunohistochemical characterization of epithelial and mesenchymal cells in canine mixed mammary tumors: putative evidence for a common histogenesis. Vet J 158:39–47CrossRefPubMedGoogle Scholar
  14. Hellmen E, Moller M, Blankenstein MA, Andersson L, Westermark B (2000) Expression of different phenotypes in cell lines from canine mammary spindle-cell tumors and osteosarcomas indicating a pluripotent mammary stem cell origin. Breast Cancer Res Treat 61:197–210CrossRefPubMedGoogle Scholar
  15. Hinrichs U, Rutteman GR, Nederbragt H (1999) Stromal accumulation of chondroitin sulphate in mammary tumors of dogs. Br J Cancer 80:1359–1365CrossRefPubMedGoogle Scholar
  16. Iozzo RV (1988) Proteoglycans and neoplasia. Cancer Metastasis Rev 7:39–50CrossRefPubMedGoogle Scholar
  17. Johansson S, Hedman K, Kjellen L, Christner J, Vaheri A, Hook M (1985) Structure and interactions of proteoglycans in the extracellular matrix produced by cultured human fibroblasts. Biochem J 232:161–168PubMedGoogle Scholar
  18. Kimata K, Oike Y, Tani K, Shinomura T, Yamagata M, Uritani M, Suzuki Z (1986) A large chondroitin sulfate proteoglycan (PG-M) synthetized before chondrogenesis in limb bud of chick embryo. J Biol Chem 261:13517–13525PubMedGoogle Scholar
  19. Kinsella MG, Bressler SL, Wight TN (2004) The regulated synthesis of versican, decorin, and biglycan: extracellular matrix proteoglycans that influence cellular phenotype. Crit Rev Eukaryot Gene Expr 14:203–234CrossRefPubMedGoogle Scholar
  20. Kusafuka K, Luyten FP, De Bondt R, Hiraki Y, Shukunami C, Kayano T, Takemura T (2003) Immunohistochemical evaluation of cartilage-derived morphogenic protein-1 and-2 in normal human salivary glands and pleomorphic adenomas. Virchows Arch Int J Pathol 442:482–490Google Scholar
  21. LeBaron RG, Zimmermann DR, Ruoslahti E (1992) Hyaluronate binding properties of versican. J Biol Chem 267:10003–10010PubMedGoogle Scholar
  22. Lee GM, Johnstone B, Jacobson K, Caterson B (1993) The Dynamic structure of the pericellular matrix on living ells. J Cell Biol 123:1899–1907CrossRefPubMedGoogle Scholar
  23. Margolis RU, Margolis RK (1994) Aggrecan-versican-neurocan family proteoglycans. Methods Enzymol 245:105–126PubMedCrossRefGoogle Scholar
  24. Matsumoto K, Shionyu M, Go M, Shimizu K, Shinomura T, Kimata K, Watanabe H (2003) Distinct interaction of versican/PG-M with hyaluronan and link protein. J Biol Chem 278:41205–41212CrossRefPubMedGoogle Scholar
  25. Misdorp W, Else RW, Hellmén E, Lipscomb TP (1999) Histological classification of mammary tumors of the dog and the cat. In: Shulmann FY (ed) WHO International Histological Classification of Tumors of Domestic Animals, 2nd edn. Armed Forced Institute of Pathology, Washington, pp 11–48Google Scholar
  26. Monlux AW, Roszel JF, MacVean DW, Palmer TW (1977) Classification of epithelial mammary tumors in a defined population. Vet Pathol 14:194–217PubMedCrossRefGoogle Scholar
  27. Nara Y, Kato Y, Torii Y, Tsuji Y, Nakagaki S, Goto S, Isobe H, Nakashima N, Takeuchi J (1997) Immunohistochemical localization of extracellular matrix components in human breast tumors with special reference to PG-M/versican. Histochem J 29:21–30CrossRefPubMedGoogle Scholar
  28. Palmer TE, Monlux AW (1979) Acid mucopolysaccharides in mammary tumors of dogs. Vet Pathol 16:493–509PubMedGoogle Scholar
  29. Pechoux C, Gudjonsson T, Ronnov-Jessen L, Bissel MJ, Petersen OW (1999) Human mammary luminal epithelial cells contain progenitors to myoepithelial cells. Dev Biol 206:88–89CrossRefPubMedGoogle Scholar
  30. Petersen OW, Nielsen HL, Gudjonsson T, Villadsen R, Ronnov-Jessen L, Bisell MJ (2001) The plasticity of human breast carcinoma cells is more than epithelial to mesenchymal conversion. Beast Cancer Res 3:213–217CrossRefGoogle Scholar
  31. Pulley LT (1973) Ultrastructural and histochemical demonstration of myoepithelium in mixed tumors of the canine mammary gland. Am J Vet Res 34:1513–1522PubMedGoogle Scholar
  32. Ricciardelli C, Mayne K, Sykes PJ, Raymond WA, McCaul K, Marshall VR, Horsfall DJ (1998) Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer. Clin Cancer Res 4:963–971PubMedGoogle Scholar
  33. Shibata S, Fukada K, Imai H, Abe T, Yamashita Y (2003) In situ hybridization and immunohistochemistry of versican, aggrecan and link protein, and histochemistry of hyaluronan in the developing mouse limb bud cartilage. J Anat 203:425–432PubMedCrossRefGoogle Scholar
  34. Shibata S, Fukada K, Suzuki S, Ogawa T, Yamashita Y (2001) Histochemical localisation of versican, aggrecan and hyaluronan in the developing condylar cartilage of the fetal rat mandible. J Anat 198:129–135CrossRefPubMedGoogle Scholar
  35. Tateyama S, Cotchin E (1977) Alkaline phosphatase reaction of canine mammary mixed tumors: a light and electronmicroscopic study. Res Vet Sci 23:356–364PubMedGoogle Scholar
  36. Tateyama S, Uchida K, Hidaka T, Hirao M, Yamaguchi R (2001) Expression of bone morphogenetic protein-6 (BMP-6) in myoepithelial cells in canine mammary gland tumors. Vet Pathol 38:703–709CrossRefPubMedGoogle Scholar
  37. Toole BP (1982) Developmental role of hyaluronate. Connect Tissue Res 10:93–100PubMedCrossRefGoogle Scholar
  38. Visco DM, Johnstone B, Hill MA, Jolly GA, Caterson B (1993) Immunohistochemical analysis of 3-B-3(-) and 7-D-4 epitope expression in canine osteoarthritis. Arthritis Rheum 36:1718–1725PubMedCrossRefGoogle Scholar
  39. Vos JH, Vandeningh T, Misdorp W, Molenbeek RF, Vanmil FN, Rutteman GR (1993) Immunohistochemistry with keratin, vimentin, desmin, and alpha- smooth muscle actin monoclonal-antibodies in canine mammary gland—benign mammary tumors and duct ectasias. Vet Q 15:89–95PubMedGoogle Scholar
  40. Wight TN (2002) Versican: a versatile extracellular matrix proteoglycan in cell biology. Cur Opin Cell Biol 14:617–623CrossRefGoogle Scholar
  41. Yamagata M, Shinomura T, Kimata K (1993) Tissue variation of two large chondroitin sulfate proteoglycans (PG-M/versican and PG-H/aggrecan) in chick embryos. Anat Embryol (Berl) 187:433–444Google Scholar
  42. Yamagata M, Kimata K (1994) Repression of a malignant cell-substratum adhesion phenotype by inhibiting the production of the anti-adhesive proteoglycan, PG-M/versican. J Cell Sci 107:2581–2590PubMedGoogle Scholar
  43. Yang BL, Zhang Y, Cao L, Yang BB (1999) Cell adhesion and proliferation mediated through the G1 domain of versican. J Cell Biochem 72:210–220CrossRefPubMedGoogle Scholar
  44. Zhang Y, Wu Y, Cao L, Lee V, Chen L, Lin Z (2001) Versican modulates embryonic chondrocyte morphology via the epidermal growth factor-like motifs in G3. Exp Cell Res 263:33–42CrossRefPubMedGoogle Scholar
  45. Zimmermann DR, Dours-Zimmermann MT, Schubert M, Bruckner-Tuderman L (1994) Versican is expressed in the proliferating zone in the epidermis and in association with the elastic network of the dermis. J Cell Biol 124:817–825CrossRefPubMedGoogle Scholar
  46. Zimmermann DR, Ruoslahti E (1989) Multiple domains of the large fibroblast proteoglycan, versican. Embo J 8:2975–2981PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • I. Erdélyi
    • 1
  • A. J. A. M. van Asten
    • 1
  • J. E. van Dijk
    • 1
  • H. Nederbragt
    • 1
  1. 1.Department of Pathobiology, Division of Pathology, Faculty of Veterinary MedicineUtrecht UniversityUtrechtThe Netherlands

Personalised recommendations